These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 38538000)

  • 21. Valproate inhibition of histone deacetylase 2 affects differentiation and decreases proliferation of endometrial stromal sarcoma cells.
    Hrzenjak A; Moinfar F; Kremser ML; Strohmeier B; Staber PB; Zatloukal K; Denk H
    Mol Cancer Ther; 2006 Sep; 5(9):2203-10. PubMed ID: 16985053
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chromodomain helicase DNA-binding 4 (CHD4) regulates early B cell identity and V(D)J recombination.
    Hagman JR; Arends T; Laborda C; Knapp JR; Harmacek L; O'Connor BP
    Immunol Rev; 2022 Jan; 305(1):29-42. PubMed ID: 34927255
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differential expression of histone deacetylases HDAC1, 2 and 3 in human breast cancer--overexpression of HDAC2 and HDAC3 is associated with clinicopathological indicators of disease progression.
    Müller BM; Jana L; Kasajima A; Lehmann A; Prinzler J; Budczies J; Winzer KJ; Dietel M; Weichert W; Denkert C
    BMC Cancer; 2013 Apr; 13():215. PubMed ID: 23627572
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CHD4 orchestrates the symphony of T and B lymphocytes development and a good mediator in preventing from autoimmune disease.
    Jia M; Zou X; Yin S; Tian W; Zhao Y; Wang H; Xu G; Cai W; Shao Q
    Immun Inflamm Dis; 2022 Jul; 10(7):e644. PubMed ID: 35759243
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunohistochemical detection of histone deacetylases in endometrial carcinoma: involvement of histone deacetylase 2 in the proliferation of endometrial carcinoma cells.
    Fakhry H; Miyamoto T; Kashima H; Suzuki A; Ke H; Konishi I; Shiozawa T
    Hum Pathol; 2010 Jun; 41(6):848-58. PubMed ID: 20178884
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CHD3 and CHD4 form distinct NuRD complexes with different yet overlapping functionality.
    Hoffmeister H; Fuchs A; Erdel F; Pinz S; Gröbner-Ferreira R; Bruckmann A; Deutzmann R; Schwartz U; Maldonado R; Huber C; Dendorfer AS; Rippe K; Längst G
    Nucleic Acids Res; 2017 Oct; 45(18):10534-10554. PubMed ID: 28977666
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The NuRD complex-mediated p21 suppression facilitates chemoresistance in BRCA-proficient breast cancer.
    Hou MF; Luo CW; Chang TM; Hung WC; Chen TY; Tsai YL; Chai CY; Pan MR
    Exp Cell Res; 2017 Oct; 359(2):458-465. PubMed ID: 28842166
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Human cytomegalovirus UL29/28 protein interacts with components of the NuRD complex which promote accumulation of immediate-early RNA.
    Terhune SS; Moorman NJ; Cristea IM; Savaryn JP; Cuevas-Bennett C; Rout MP; Chait BT; Shenk T
    PLoS Pathog; 2010 Jun; 6(6):e1000965. PubMed ID: 20585571
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification and characterization of novel proteins associated with CHD4.
    Sakaguchi C; Ichihara K; Nita A; Katayama Y; Nakayama KI
    Genes Cells; 2022 Jan; 27(1):61-71. PubMed ID: 34897913
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular architecture of nucleosome remodeling and deacetylase sub-complexes by integrative structure determination.
    Arvindekar S; Jackman MJ; Low JKK; Landsberg MJ; Mackay JP; Viswanath S
    Protein Sci; 2022 Sep; 31(9):e4387. PubMed ID: 36040254
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinicopathological features and prediction values of HDAC1, HDAC2, HDAC3, and HDAC11 in classical Hodgkin lymphoma.
    Huang R; Zhang X; Sophia S; Min Z; Liu X
    Anticancer Drugs; 2018 Apr; 29(4):364-370. PubMed ID: 29481474
    [TBL] [Abstract][Full Text] [Related]  

  • 32. De Novo Mutations in CHD4, an ATP-Dependent Chromatin Remodeler Gene, Cause an Intellectual Disability Syndrome with Distinctive Dysmorphisms.
    Weiss K; Terhal PA; Cohen L; Bruccoleri M; Irving M; Martinez AF; Rosenfeld JA; Machol K; Yang Y; Liu P; Walkiewicz M; Beuten J; Gomez-Ospina N; Haude K; Fong CT; Enns GM; Bernstein JA; Fan J; Gotway G; Ghorbani M; ; van Gassen K; Monroe GR; van Haaften G; Basel-Vanagaite L; Yang XJ; Campeau PM; Muenke M
    Am J Hum Genet; 2016 Oct; 99(4):934-941. PubMed ID: 27616479
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Type-specific roles of histone deacetylase (HDAC) overexpression in ovarian carcinoma: HDAC1 enhances cell proliferation and HDAC3 stimulates cell migration with downregulation of E-cadherin.
    Hayashi A; Horiuchi A; Kikuchi N; Hayashi T; Fuseya C; Suzuki A; Konishi I; Shiozawa T
    Int J Cancer; 2010 Sep; 127(6):1332-46. PubMed ID: 20049841
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Coexpression of SALL4 with HDAC1 and/or HDAC2 is associated with underexpression of PTEN and poor prognosis in patients with hepatocellular carcinoma.
    Wang H; Kohashi K; Yoshizumi T; Okumura Y; Tanaka Y; Shimokawa M; Iwasaki T; Aishima S; Maehara Y; Oda Y
    Hum Pathol; 2017 Jun; 64():69-75. PubMed ID: 28411180
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Analysis of the complex between MBD2 and the histone deacetylase core of NuRD reveals key interactions critical for gene silencing.
    Leighton GO; Shang S; Hageman S; Ginder GD; Williams DC
    Proc Natl Acad Sci U S A; 2023 Aug; 120(33):e2307287120. PubMed ID: 37552759
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An ikaros-containing chromatin-remodeling complex in adult-type erythroid cells.
    O'Neill DW; Schoetz SS; Lopez RA; Castle M; Rabinowitz L; Shor E; Krawchuk D; Goll MG; Renz M; Seelig HP; Han S; Seong RH; Park SD; Agalioti T; Munshi N; Thanos D; Erdjument-Bromage H; Tempst P; Bank A
    Mol Cell Biol; 2000 Oct; 20(20):7572-82. PubMed ID: 11003653
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Acetyltransferase p300 collaborates with chromodomain helicase DNA-binding protein 4 (CHD4) to facilitate DNA double-strand break repair.
    Qi W; Chen H; Xiao T; Wang R; Li T; Han L; Zeng X
    Mutagenesis; 2016 Mar; 31(2):193-203. PubMed ID: 26546801
    [TBL] [Abstract][Full Text] [Related]  

  • 38. β1 integrin signaling governs necroptosis via the chromatin-remodeling factor CHD4.
    Sun Z; Cernilogar FM; Horvatic H; Yeroslaviz A; Abdullah Z; Schotta G; Hornung V
    Cell Rep; 2023 Nov; 42(11):113322. PubMed ID: 37883227
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The epigenetic factor CHD4 contributes to metastasis by regulating the EZH2/β-catenin axis and acts as a therapeutic target in ovarian cancer.
    Wang J; Zhong F; Li J; Yue H; Li W; Lu X
    J Transl Med; 2023 Jan; 21(1):38. PubMed ID: 36681835
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mi2, an auto-antigen for dermatomyositis, is an ATP-dependent nucleosome remodeling factor.
    Wang HB; Zhang Y
    Nucleic Acids Res; 2001 Jun; 29(12):2517-21. PubMed ID: 11410659
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.